Innovation in Personalized Cannabis Care

Imagine walking into a dispensary for the first time to help alleviate a medical condition. You might come across dozens of different cannabis varieties. These products may be available in buds, oils, capsules, edibles, patches and other forms. And once you decide on the right product, you might receive different advice from different people about how much you should consume.

There are 779 different strains of cannabis being actively cultivated and differences between cannabinoid and terpene profiles, delivery mechanisms, and even an individual’s own metabolism can yield very different experiences between medical marijuana patients. This makes strain selection, delivery mechanisms, and dosing incredibly important for effective treatment of underlying medical conditions.

Resolve Digital Health Inc. aims to improve the patient experience by introducing a Smart Inhaler that allows patients to access the best strain for their condition and fine-tune the exact dose to their personal needs at any given point in time – a methodology they refer to as personalized medicine.

Click here to stay up to date on Resolve Digital Health developments.

Personalized Medicine’s Potential

Western physicians have traditionally relied on a “one size fits all” approach when it comes to prescribing pharmaceuticals and treatments for their patients. This is rapidly changing with the introduction of personalized medicine, which tailors medical decisions, prescriptions, practices, and interventions to an individual rather than generalizing it to a population. The result is a vastly superior patient experience and clinical outcomes in most cases.

The global personalized medicine industry is projected to grow at a 9.4% compound annual growth rate to approximately $233.4 billion by 2025, according to Research and Markets. Some of the most prominent trends in the market include the rising use of biomarkers for personalized medicine cancer therapy, genomic medicine that incorporates a patient’s genetic profile, and medical devices that offer better diagnostic Continue Reading

Evolve hosts Charity Food Truck Lunch at LIGHTSHADE – PEORIA Dispensary

Evolve Formulas’ Dispensary Luncheon Feeds Homeless with One-For-One System What:   Join Evolve Formulas, a brand of NanoSphere Health Sciences, for a special cannabis dispensary lunch in aid of homelessness charity Kitchen One for One! This Evolve Formulas’ lunch will provide free meals at Lightshade – Peoria to show their appreciation for their key dispensary partner, for Lightshade customers and to share the love with a great cause. A food truck serving a mouth-watering menu of tacos, nachos and quesadillas will be on site at Lightshade – Peoria, offering a free meal to the homeless for each meal served. Free lunch will be provided to anyone who makes a Lightshade purchase during the allocated time and to Lightshade employees from any location – so come down to kick off your weekend with free food and the best of cannabis products. Be sure to check out the Evolve Transdermal NanoSerum™, in … Continue reading

FinCanna Signs Binding Term Sheet with Cannabis Extraction Company in Oakland, California

VANCOUVER, British Columbia, Feb. 15, 2018 (GLOBE NEWSWIRE) — FinCanna Capital Corp. (“FinCanna”) (CSE:CALI), have signed a binding term sheet with Gram Co Holdings LLC (“Gram Co”), subject to due diligence by FinCanna. Gram Co, based in Oakland, California, is a cannabinoid research and refinement facility focussed on the medical cannabis industry to provide B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers and numerous others in the cannabis supply chain.  Gram Co has leased a facility in Oakland, California in which they are retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating by the end of the third quarter of 2018.  Gram Co plans to be a premier producer of bulk quantities of THC distillate and various concentrates produced via hydrocarbon-based solvent extraction. Gram Co also plans to provide white labeling services to licensed brand and infused product manufacturers who … Continue reading

Future Farm Receives Three Industrial Hemp Licenses for 2018

Vancouver, BC, Feb. 15, 2018 (GLOBE NEWSWIRE) — Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that its subsidiary, Future Farm Maine, LLC, has received three licenses from the State of Maine for the cultivation of industrial hemp in 2018. Future Farm Maine received one license for each of its Amity and Hersey farms, as well as one for the Belfast processing facility. Mr. Bill Gildea, CEO of Future Farm comments, “We are thrilled to have received these three licenses to operate our industrial hemp business in Maine and are excited to build our high value, vertically integrated industrial hemp farm and CBD oil production facility in 2018.” As recently announced, the Company signed a lease agreement for an initial 12,960 sq. ft. of space in a 60,000 sq. ft. building, with an option to expand or buy the building.  Future … Continue reading

Ehave Enters Blockchain Market for Secure Access of Patient Data in Mental Healthcare and Medical Cannabis

TORONTO, ON / ACCESSWIRE / February 15, 2018 / Ehave, Inc. (EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced that the the Company will expand its informatics solution to include Blockchain Technology. With careful consideration and research into the market needs of mental healthcare and medical cannabis, the Company sees an opportunity to implement Blockchain solutions that are driven from a patient focused strategy, rather than a technology first approach. IDC (Jan 2018) is predicting that global spend on blockchain will reach $2.1 billion in 2018, and that regulator’s positive comments about blockchain will “help accelerate demand in regulated industries such as … healthcare”. So far, Blockchain has primarily been used by cryptocurrency implementations to provide a decentralized consensus platform for validating financial transactions. Ehave is looking at applying and improving the principles behind current Blockchain technology to allow patients greater control over … Continue reading

RISE and Constance Therapeutics Join Forces, Marrying Cannabis and Sexual Health

The recent partnership between Luminor Medical Technologies Inc. (CSE: LMT), soon to be called RISE Life Science Corp., and Constance Therapeutics takes aim at two large and growing markets: legal cannabis products and sexual health. The companies have agreed to develop and market cannabis-based sexual health products, starting this year in California. California’s cannabis revenue is projected to reach $3.7 billion in 2018 and rise to $5.1 billion in 2019, according to BDS Analytics. These revenues are poised to continue to grow as the market matures and more dispensaries and cultivation operations come online. Meanwhile, according to Grand View Research, the U.S. sexual wellness market is projected to reach $8.8 billion by 2025, driven by the aging population and the introduction of new and innovative products. Let’s take a look at just what these two companies have planned and why it merits attention. Constance Therapeutics is a Force in the … Continue reading

When to Harvest Cannabis

Harvesting cannabis at the right time means that the crop will have the most potent cannabinoids it can for its strain, so it is essential to nail harvesting time accurately. Growing cannabis can take two or more months, so losing potency by harvesting early or too late can set you or your business back by nearly an entire fiscal quarter in the worst cases of botched harvest jobs. Luckily, identifying changes in your cannabis plants can give you clear insight as to when your harvest will be optimal. Stages of a Cannabis Harvest First, let’s recap on the stages of growing cannabis that precede harvest time, just to establish a timeline that will dispel confusion as to when to start preparing for harvest. Week 1: Germination and sprouts. Week 2: First nodes. Week 3: First week switched to 12/12 light, or beginning of autumn for outdoor. Week 4: First signs of … Continue reading

In Route to Becoming Fully Reporting, SinglePoint Up-Lists to OTCQB and adds Former Amazon GM as Additional Board Member

SEATTLE, Feb. 14, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — SinglePoint Inc. (SING) provides shareholder update on recent OTCQB up-list, company overview and adding key board member to help guide company technology initiatives. SinglePoint is currently engaged with auditor to complete 2017 audit and become fully reporting soon. Becoming fully reporting should increase the exposure of SinglePoint to institutional investors for direct investment as well as through the open market. In addition to this the company looks to increase transparency and credibility for its shareholders and ultimately increase the value of SinglePoint. A requirement of the company’s move to the OTCQB Venture Markets was to add an additional board member. SinglePoint has added previous Amazon General Manager and current F5 Networks Senior Vice President Venugopal Aravamudan. Mr. Aravamudan has a 25+ years tenure in the technology sector growing and leading significant businesses at companies such as Microsoft, VMware, … Continue reading

NanoSphere Health Offers Six-Fold Improvement in Cannabinoid Bioavailability

The U.S. cannabis industry is projected to exceed $50 billion in size over the coming years, according to Cowen & Co., driven by the legalization of adult-use cannabis in California and other states. While there are many opportunities for investors in the space, since they generate high-margin licensing revenue and don’t touch the plant, biotech firms developing innovative delivery mechanisms offer investors a compelling opportunity. NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) has developed an innovative delivery technology that solves key issues related to cannabinoid bioavailability. With an existing licensing agreement, the company is also well on its way to commercialization after spending more than a decade fine-tuning its technology–and developing products that have applications across an array of industries. Investors may want to take a closer look at the stock as a potential opportunity in the space. Cannabinoid Bioavailability The issue of bioavailability is a major problem facing … Continue reading

Smart Cannabis Expands Joint Venture with SinglePoint

SACRAMENTO, Calif., Feb. 13, 2018 /PRNewswire/ — Smart Cannabis Corp, (SCNA), announced today it has significantly broadened its joint venture agreement with Singlepoint, Inc., (SING) providing SinglePoint with the rights to sell Smart Cannabis’ Smart by Design greenhouses. This provides Smart Cannabis additional footprint to grow its base and SinglePoint access to some of the best greenhouses on the market. Under terms of the agreement, SinglePoint will be have an exclusive agreement on Smart Cannabis products sold and installed within Arizona, which includes the company’s line of SMART by Design™ automated greenhouse systems including the SMARTAPP automation software product, and the soon-to-be-released “Track and Trace Software System.” Arizona is one of the nation’s largest MMJ Markets and show no signs of slowing down. Most recently bipartisan legislation was introduced through House Concurrent Resolution 2037 that would allow legalized marijuana of one ounce or less for personal use. According to Phoenix New Times and Arizona Department of Health Services, medical cannabis … Continue reading